Enter your login e-mail to the account
Search
Search parameters
Search results
- DÔLEŽITÉ POJMY V0 FARMAKOEKONOMIKE (2. časť)
doc. PhDr. Róbert Babeľa, PhD., prof. RNDr. Viliam Foltán, CSc., MUDr. Adriana Ilavská, PharmDr. Tomáš Tesař1, Phd., MBA
(3/2008, Pharmacoeconomics ) - The transferability of pharmacoeconomic studies results between countries
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. MUDr. Róbert Babeľa, PhD.
(1/2009, Pharmacoeconomics ) - Redakčný stĺpček
Magda Žiaková
(1/2009, Editorial column ) - Overview of resulsts in selected phramacoeconomic study of betablocker carvedilol
Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA, doc. PharmDr. Tomáš Tesař, PhD., MBA
(6/2009, Pharmacoeconomics ) - Novinky vo farmakoterapii: Kategorizácia od 1. júla 2009
Ing. Mgr. Dagmar Hroncová
(6/2009, Information & comments ) - MEDICÍNA PRE PRAX – SPRÁVA ZO 4. ROČNÍKA KONGRESU LEKÁROV PRVÉHO KONTAKTU
MUDr. Jozef Jakuš
(9/2008, Events ) - Overview of results in selected pharmacoeconomic studies with valsartan
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
(11/2009, Pharmacoeconomics ) - Overview of results in selected pharmacoeconomic study of irbesartan
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
(12/2009, Pharmacoeconomics ) - EFFECIIVE AND SAFE PHARMACOTHERAPY FOR SENIORS
MUDr. Martin Dúbrava, CSc.
(7-8/2006, Main topic ) - Overview of results in selected in pharmacoeconomic study of ACEi ramipril
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
(2/2009, Pharmacoeconomics ) - HISTÓRIA FARMAKOEKONOMIKY A ZÁKLADNÁ DEFINÍCIA
doc. PhDr. Róbert Babeľa, PhD., PharmDr. Tomáš Tesař, PhD., MBA, prof. RNDr. Viliam Foltán, CSc., MUDr. Adriana Ilavská
(1/2008, Pharmacoeconomics ) - AZITHROMYCIN USE IN THE TREATMENT OF ERYTHEMA MIGRANS
doc. MUDr. Pavol Jarčuška, PhD.
(4/2007, clearly ) - Overview of results in selected in pharmacoeconomic study of ACEi perindopril
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
(3/2009, Pharmacoeconomics ) - IT IS POSSIBLE TO AWAIT FROM „DISEASE MANAGEMENT PROGRAM“ PROFESSIONAL, ECONOMICAL PROFITABLY CARE OF DIABETICS 2. TYPE?
doc. MUDr. Boris Krahulec, CSc., Dr. med. Valerien Sulik
(10/2007, Spectrum ) - FARMAKOEKONOMIKA – KOMPLEXNÝ POHĽAD NA ZDRAVOTNÚ STAROSTLIVOSŤ
doc. PhDr. Róbert Babeľa, PhD., prof. RNDr. Viliam Foltán, CSc., MUDr. Adriana Ilavská, PharmDr. Tomáš Tesař, PhD.
(4-5/2008, Pharmacoeconomics ) - ECONOMIC EVALUATION IN HEALTHCARE SYSTEM
doc. PhDr. Róbert Babeľa, PhD., prof. RNDr. Viliam Foltán, CSc., MUDr. Adriana Ilavská, PharmDr. Tomáš Tesař, PhD.
(6/2008, Pharmacoeconomics ) - Odporúčaný postup diagnostiky a liečby kolitídy spôsobenej Clostridium difficile
(S1/2015, Guidelines ) - Osteoporosis and quality of life
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., Mgr. Tomáš Ďurdík
(6/2015, Review articles ) - FARMAKOEKONOMIKA A HODNOTENIE KVALITY ŽIVOTA PACIENTOV
doc. PhDr. Róbert Babeľa, PhD., prof. RNDr. Viliam Foltán, CSc., MUDr. Adriana Ilavská, PharmDr. Tomáš Tesař, PhD.
(7-8/2008, Pharmacoeconomics ) - Overview of results in selected pharmacoeconomic study of betablocker bisoprolol
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
(5/2009, Pharmacoeconomics ) - Early diagnostic of chronic obstructive pulmonary disease, therapy and their pharmacoeconomy profits
MUDr. Ján Dindoš
(6/2011, Review articles ) - IMPORTANCE OF PHARMACOECONOMICS IN DECISION-MAKING OF PRIMARY CARE PHYSICIANS
doc. PhDr. Róbert Babeľa, PhD., PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon
(12/2008, Pharmacoeconomics ) - ZDRUŽENIE NA POMOC PACIENTOM S LEUKÉMIOU A LYMFÓMOM
JUDr. Eva Madajová
(12/2008, Focus )
- Léčba poruch příjmu jídla na Psychiatrické klinice v Hradci Králové
doc. MUDr. Ladislav Hosák, Ph.D.
(2/2007, Case reports ) - Vagus nerve stimulation in treatment-resistant depression
MUDr. Jozef Dragašek, PhD.
(2–3/2010, Review articles ) - Vagus nerve stimulation in treatment-resistant depression
MUDr. Jozef Dragašek, PhD.
(2–3/2010, Review articles ) - Vagus nerve stimulation in treatment-resistant depression
MUDr. Jozef Dragašek, PhD.
(2–3/2010, Review articles ) - COMPARISON OF THE COST OF TREATMENT OF MAJOR DEPRESSIVE EPIZODE WITH ESCITALOPRAM AND A GENERIC CITALOPRAM BY MEANS OF A PHARMACOECONOMIC MODEL
doc. MUDr. Václav Filip, CSc., prof. RNDr. Jaromír Antoch, DrSc., MUDr. Jaroslava Skopová
(3/2005, Review articles ) - Metabolic syndrome in the context of psychiatric disorders and psychotropic treatment
MUDr. Jozef Dragašek, PhD.
(1/2014, Review articles ) - Pharmacoeconomy, patients and psychiatrists
MUDr. Jaroslav Vaněk, MUDr. PhDr. David Vaněk
(1/2001, Review articles )
- Publikujeme v zahraničí / Zo zahraničnej tlače
(6/2005, Papers from literature ) - Štruktúra rehospitalizovaných pacientov II. Neurologickej kliniky LF UK
MUDr. Milan Liška, prof. MUDr. Peter Kukumberg PhD.
(5/2004, Case reports ) - Zimné dni sclerosis multiplex – 2. ročník 17. – 18. január 2014, Vysoké Tatry
(2/2014, Abstracts )
- PHARMACOECONOMICS – ITS POSITION IN DRUG POLICY
prof. MUDr. Jozef Holomáň, CSc.
(1/2008, Review articles ) - PHARMACOECONOMICAL EVALUATION OF ONCOLOGY DRUGS – DIFFICULTIES AND POSSIBLE SOLUTIONS
doc. MUDr. Ján Bielik, CSc., PharmDr. Dominikk Tomek, MPH
(1/2008, Review articles ) - PHARMACOECONOMICS – ITS POSITION IN DRUG POLICY
prof. RNDr. Viliam Foltán, CSc., Mgr. Veronika Dubajová, PharmDr. Tomáš Tesař, PHD, MBA
(1/2008, Review articles ) - PHARMACOECONOMICS OF ONCOLOGIC TREATMENT FORM THE POINT OF VIEW OF HEALTH INSURANCE COMPANY
MUDr. Alexander Paluch, MUDr. Lucia Vitárius, MPH
(1/2008, Review articles ) - Pharmacoeconomics and ethics in oncology: ethical dilemmas and possible solutions
Prof. MUDr. Jozef Glasa, CSc., PhD., MUDr. Helena Glasová, PhD.
(1/2014, Main topic ) - Komentár k článku: Farmakoekonomika a etika v onkológii: etické dilemy a možnosti ich riešenia
MUDr. Kristina Križanová
(1/2014, Main topic ) - Použitie rastových faktorov myelopoézy v profylaxii febrilnej neutropénie
MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Ivana Plameňová, PhD., MUDr. Ľubica Váleková, PhD., Prof. MUDr. Ján Staško, PhD.
(2/2018, Review articles ) - ANTIBACTERIAL PROPHYLAXIS IN NEUTROPENIC CANCER PATIENTS
h. doc. MUDr. Ľuboš Drgoňa
(5/2007, Review articles )
- Acne – An overview, news in the treatment
MUDr. Katařina Fajkošová
(4/2011, Review articles )
- SPRÁVA Z XXIV. ZJAZDU SLOVENSKÝCH A ČESKÝCH ALERGOLÓGOV A KLINICKÝCH IMUNOLÓGOV V TRNAVE 24. – 27. 10. 2007
doc. MUDr. Martin Hrubiško, PhD.
(3-4/2007, clearly )
- Osteoporosis and quality of life
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., Mgr. Tomáš Ďurdík
(4/2014, Current pharmacotherapy ) - Trends in consumption of drugs for respiratory system in the Slovak Republic
Doc. PharmDr. Tomáš Tesař, PhD., MPH, MBA, MSc (HTA), PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD.
(1/2018, Clinical pharmacy ) - The role of the clinical pharmacist in the health care in Teaching hospital Nitra
PharmDr. Mária Göböová, PhD.
(4/2016, Pharmacy )
- Prophylaxis of venous thromboembolism in orthopaedic surgery
MUDr. Peter Maresch, CSc.
(1/2010, Main topic ) - Biosimilars – generic copies of various types of biotech drugs?
doc. MUDr. Ján Staško, PhD., prof. MUDr. Peter Kubisz, DrSc., MUDr. Juraj Chudej, PhD., MUDr. Pavol Hollý, PhD., MUDr. Juraj Sokol, PhD.
(1/2015, Review articles )